Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid
NCT03710005 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2024-07-01
Summary
To compare the efficacy of Ascent injection versus corticosteroid injection in treating knee osteoarthritis.
Conditions
Interventions
- PROCEDURE
-
Ascent
Dehydrated Cell and Protein Concentrate injection
- PROCEDURE
-
Standard
Standard corticosteroid injection
Sponsors & Collaborators
-
StimLabs
lead INDUSTRY
Principal Investigators
-
Oluseun Olufade, MD · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-22
- Primary Completion
- 2021-05-31
- Completion
- 2021-05-31
Countries
- United States
Study Locations
More Related Trials
-
Platelet-Rich Plasma vs Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint
NCT01920373 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears
NCT04088227 ·Status: COMPLETED ·Phase: PHASE2
-
Geniculate Artery Embolization for Knee Osteoarthritis
NCT03835988 ·Status: WITHDRAWN ·Phase: NA
-
Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial
NCT04351087 ·Status: COMPLETED ·Phase: NA
-
Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions
NCT00945399 ·Status: TERMINATED ·Phase: PHASE3
-
Platelet Rich Plasma Injections In Young And Old Human Subjects
NCT06451120 ·Status: RECRUITING ·Phase: PHASE2
-
PRP vs HA Intra-articular Knee Injections for Cartilage Defects
NCT02012530 ·Status: UNKNOWN ·Phase: NA
-
Effects of Steroid, Dextrose Prolotherapy, and Platelet-Rich Plasma Injections in Knee Joint OA Patients
NCT07243392 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement
NCT02920177 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Intra-articular Injection of Autologous Protein Solution ("APS(TM)") for the Treatment of Osteoarthritis (OA)
NCT01773226 ·Status: COMPLETED ·Phase: NA
-
Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
NCT04331002 ·Status: TERMINATED ·Phase: PHASE2
-
IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.
NCT02037204 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Platelet Rich Plasma in Knee Osteoarthritis
NCT05080075 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study
NCT03898388 ·Status: TERMINATED ·Phase: NA
-
The SpeedPlate™ Rapid Compression Implant Study (The SPRINT™ Study)
NCT06548581 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid.
NCT02958761 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Trial of the TriFit™ Web Knee Brace
NCT03633071 ·Status: TERMINATED
-
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
NCT02768155 ·Status: COMPLETED ·Phase: NA
-
Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis
NCT03810521 ·Status: UNKNOWN ·Phase: PHASE1
-
The MONOVISC Hip Osteoarthritis Study
NCT02698865 ·Status: TERMINATED ·Phase: PHASE3
-
APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee
NCT02210468 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA
NCT02351011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
NCT05737173 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Teriparatide for Improved Knee Prosthesis Fixation
NCT01063504 ·Status: COMPLETED ·Phase: PHASE2
-
pAF for the Treatment of Osteoarthritis
NCT04886960 ·Status: COMPLETED ·Phase: PHASE1/PHASE2